| CEVYX | DOXWX | CEVYX / DOXWX | |
| Total Expense Ratio | 0.77 | 0.52 | 148% |
| Annual Report Gross Expense Ratio | 0.77 | 0.57 | 135% |
| Fund Existence | 13 years | 4 years | - |
| Gain YTD | 17.796 | 22.976 | 77% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 2500 | 40,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 846M | 12.6B | 7% |
| Annual Yield % from dividends | 2.04 | 1.66 | 123% |
| Returns for 1 year | 9.95 | 3.96 | 251% |
| Returns for 3 years | 29.40 | 30.70 | 96% |
| Returns for 5 years | 27.74 | N/A | - |
| Returns for 10 years | 39.03 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HAWX | 39.83 | 0.23 | +0.58% |
| iShares Currency Hdgd MSCI ACWI exUS ETF | |||
| JFR | 7.99 | 0.02 | +0.25% |
| Nuveen Floating Rate Income Fund | |||
| FLQS | 42.76 | -0.02 | -0.04% |
| Franklin US Small Cap Mltfctr Idx ETF | |||
| DUKH | 24.43 | -0.02 | -0.08% |
| Ocean Park High Income ETF | |||
| BIS | 10.19 | -0.05 | -0.51% |
| ProShares UltraShort Nasdaq Biotech | |||